Value creation priorities shaping medtech
麦肯锡·2024-10-17 00:08
McKinsey Life Sciences Practice Value creation priorities shaping medtech With pandemic-related volatility subsiding, the strategies separating industry leaders from their peers are coming into focus. by Delphine Nain Zurkiya, Gerti Pellumbi, Peter Pfeiffer, and Tommy Reid October 2024 Medtech value creation has been a story of haves and have-nots in recent years. Since 2019, the top value creators have outpaced the S&P 500, while the rest of the industry has struggled (Exhibit 1).1 Industry and capital mar ...